Lenio 20 mg and 30 mg TABLET
PDF Leaflet Revision Date: 26 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Depression, OCD, Social phobia, Panic disorder.
Dosage (summary)
Starting at 20 mg daily, max 50 mg for depression; 40 mg daily for panic disorder; 40 mg daily for OCD; 20 mg daily for social phobia.
Onset of Action / Duration
Onset: 7-14 days, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established.
Key Drug Interactions
- MAO inhibitors
- Thioridazine
- Cimetidine
- Phenytoin
- Risperidone
- Lithium
- Warfarin
Contraindications
- Hypersensitivity to paroxetine
- MAO inhibitors
- Children under 18
- Co-administration with thioridazine
Common side effects
- Somnolence
- Insomnia
- Nausea
- Dizziness
- Sexual dysfunction
Counselling Points
- Take in the morning with food
- Do not abruptly discontinue
- Caution with driving and machinery
- Avoid alcohol
Serious warnings
- Risk of suicidal ideation in children and adolescents
- Monitor for worsening depression
- Caution in patients with epilepsy
Important Disclaimer
The Lenio 20 mg and 30 mg TABLET professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
